Filip Bergquist

3.2k total citations
65 papers, 2.4k citations indexed

About

Filip Bergquist is a scholar working on Neurology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Filip Bergquist has authored 65 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Neurology, 13 papers in Cellular and Molecular Neuroscience and 10 papers in Neurology. Recurrent topics in Filip Bergquist's work include Parkinson's Disease Mechanisms and Treatments (36 papers), Neurological disorders and treatments (33 papers) and Botulinum Toxin and Related Neurological Disorders (11 papers). Filip Bergquist is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (36 papers), Neurological disorders and treatments (33 papers) and Botulinum Toxin and Related Neurological Disorders (11 papers). Filip Bergquist collaborates with scholars based in Sweden, United Kingdom and United States. Filip Bergquist's co-authors include Hans Nissbrandt, Karolina P. Skibicka, Caroline Hansson, Mayank B. Dutia, Suzanne L. Dickson, Mike Ludwig, Rozita H. Anderberg, Malcolm Horne, Dag Nyholm and Mevludin Memedi and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Filip Bergquist

64 papers receiving 2.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Filip Bergquist 730 694 596 405 312 65 2.4k
Bin Hu 516 0.7× 1.4k 1.9× 504 0.8× 255 0.6× 270 0.9× 125 3.1k
Walter Pirker 2.2k 3.0× 1.5k 2.2× 367 0.6× 114 0.3× 344 1.1× 75 3.9k
M.K. Horne 459 0.6× 613 0.9× 247 0.4× 137 0.3× 186 0.6× 33 1.7k
Miguel A. Pozo 168 0.2× 766 1.1× 404 0.7× 150 0.4× 155 0.5× 93 2.6k
Helen E. Savaki 536 0.7× 1.5k 2.1× 714 1.2× 146 0.4× 319 1.0× 68 3.0k
Deniz Yilmazer‐Hanke 626 0.9× 935 1.3× 418 0.7× 92 0.2× 358 1.1× 74 2.4k
Donald H. York 393 0.5× 1.1k 1.6× 569 1.0× 155 0.4× 323 1.0× 67 2.4k
Jose M. Rabey 719 1.0× 691 1.0× 533 0.9× 96 0.2× 510 1.6× 59 2.5k
Bret N. Smith 340 0.5× 1.6k 2.3× 814 1.4× 1.3k 3.1× 233 0.7× 100 3.7k
Vincenzo Parisi 505 0.7× 711 1.0× 1.9k 3.1× 177 0.4× 1.4k 4.4× 195 6.5k

Countries citing papers authored by Filip Bergquist

Since Specialization
Citations

This map shows the geographic impact of Filip Bergquist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Filip Bergquist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Filip Bergquist more than expected).

Fields of papers citing papers by Filip Bergquist

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Filip Bergquist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Filip Bergquist. The network helps show where Filip Bergquist may publish in the future.

Co-authorship network of co-authors of Filip Bergquist

This figure shows the co-authorship network connecting the top 25 collaborators of Filip Bergquist. A scholar is included among the top collaborators of Filip Bergquist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Filip Bergquist. Filip Bergquist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bergquist, Filip, Per Odin, Anders Johansson, et al.. (2024). Levodopa–entacapone–carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease. European Journal of Neurology. 32(1). e16582–e16582. 3 indexed citations
2.
Chaudhuri, К. Ray, Maurizio Facheris, Bruno Bergmans, et al.. (2024). Improved Sleep Correlates with Improved Quality of Life and Motor Symptoms with Foslevodopa/Foscarbidopa. Movement Disorders Clinical Practice. 11(7). 861–866. 8 indexed citations
3.
Bergquist, Filip, M. Ehrnebo, Dag Nyholm, et al.. (2024). Motor Efficacy of Subcutaneous DIZ102, Intravenous DIZ101 or Intestinal Levodopa/Carbidopa Infusion. Movement Disorders Clinical Practice. 11(9). 1095–1102. 3 indexed citations
4.
Wallerstedt, Susanna M., et al.. (2023). Validation of the Swedish Patient‐Reported Outcomes in Parkinson's Disease Scale in Outpatients. Movement Disorders. 38(9). 1668–1678. 4 indexed citations
5.
Bergquist, Filip, M. Ehrnebo, Dag Nyholm, et al.. (2022). Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease. Neurology. 99(10). e965–e976. 15 indexed citations
6.
Hagell, Peter, et al.. (2020). Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson’s disease. Journal of Neurology. 267(11). 3411–3417. 4 indexed citations
7.
Bergquist, Filip, et al.. (2020). Activation of glucagon‐like peptide‐1 receptors and skilled reach foraging. Addiction Biology. 26(3). e12953–e12953. 5 indexed citations
8.
9.
Buvarp, Dongni, Ilias Thomas, Anders Ericsson, et al.. (2019). Evaluation of a sensor algorithm for motor state rating in Parkinson's disease. Parkinsonism & Related Disorders. 64. 112–117. 5 indexed citations
10.
Thomas, Ilias, Jerker Westin, Moudud Alam, et al.. (2017). A Treatment-Response Index From Wearable Sensors for Quantifying Parkinson's Disease Motor States. IEEE Journal of Biomedical and Health Informatics. 22(5). 1341–1349. 40 indexed citations
11.
Ozanne, Anneli, et al.. (2017). Wearables in epilepsy and Parkinson's disease—A focus group study. Acta Neurologica Scandinavica. 137(2). 188–194. 68 indexed citations
12.
Senek, Marina, Sten‐Magnus Aquilonius, Håkan Askmark, et al.. (2017). Levodopa/carbidopa microtablets in Parkinson’s disease: a study of pharmacokinetics and blinded motor assessment. European Journal of Clinical Pharmacology. 73(5). 563–571. 38 indexed citations
13.
Söderlund, Göran, et al.. (2016). PT544. The effect of acoustic white noise on motor learning and correlation with neural activity in an animal model of ADHD.. The International Journal of Neuropsychopharmacology. 19(Suppl_1). 1–1. 8 indexed citations
14.
Bergquist, Filip, et al.. (2013). The Discriminating Properties of an Optoelectronic Movement Analysis Method in Patients With Parkinsonism. Journal of Motor Behavior. 45(5). 415–422. 1 indexed citations
15.
Dickson, Suzanne L., et al.. (2012). The Glucagon-Like Peptide 1 (GLP-1) Analogue, Exendin-4, Decreases the Rewarding Value of Food: A New Role for Mesolimbic GLP-1 Receptors. Journal of Neuroscience. 32(14). 4812–4820. 332 indexed citations
16.
Bergquist, Filip, Mike Ludwig, & Mayank B. Dutia. (2008). Role of the commissural inhibitory system in vestibular compensation in the rat. The Journal of Physiology. 586(18). 4441–4452. 61 indexed citations
17.
Andersson, Daniel, Hans Nissbrandt, & Filip Bergquist. (2006). Partial depletion of dopamine in substantia nigra impairs motor performance without altering striatal dopamine neurotransmission. European Journal of Neuroscience. 24(2). 617–624. 51 indexed citations
18.
Bergquist, Filip, A. Ruthven, Mike Ludwig, & Mayank B. Dutia. (2006). Histaminergic and glycinergic modulation of GABA release in the vestibular nuclei of normal and labyrinthectomised rats. The Journal of Physiology. 577(3). 857–868. 55 indexed citations
19.
Bergquist, Filip, et al.. (2002). Evidence for different exocytosis pathways in dendritic and terminal dopamine release in vivo. Brain Research. 950(1-2). 245–253. 44 indexed citations
20.
Bergquist, Filip, Jan Jonason, Erik Pileblad, & Hans Nissbrandt. (1998). Effects of Local Administration of L‐, N‐, and P/Q‐Type Calcium Channel Blockers on Spontaneous Dopamine Release in the Striatum and the Substantia Nigra: A Microdialysis Study in Rat. Journal of Neurochemistry. 70(4). 1532–1540. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bin Hu Breakdown of academic impact, for papers by Walter Pirker Breakdown of academic impact, for papers by M.K. Horne Breakdown of academic impact, for papers by Miguel A. Pozo Breakdown of academic impact, for papers by Helen E. Savaki Breakdown of academic impact, for papers by Deniz Yilmazer‐Hanke Breakdown of academic impact, for papers by Donald H. York Breakdown of academic impact, for papers by Jose M. Rabey Breakdown of academic impact, for papers by Bret N. Smith Breakdown of academic impact, for papers by Vincenzo Parisi
Rankless by CCL
2026